Health

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 ReadyRx Prescription Telehealth Analysis

CHEYENNE, WY, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute…

1 month ago

Etienna Bio Secures Exclusive Worldwide License from UMass Chan Medical School for Novel Adipose-Derived Regenerative Platform

LEAWOOD, Kan., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Etienna Bio, Inc., a biotechnology company focused on next-generation autologous and cell-enabled…

1 month ago

Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference

- Rapidly transforming into a leading global biopharma company January 09, 2026 18:01 ET  | Source: Ascendis Pharma COPENHAGEN, Denmark,…

1 month ago

Cooper Aerobics Partners with The Stayton at Museum Way

DALLAS and FORT WORTH, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cooper Wellness Strategies (CWS), a Cooper Aerobics company, expands…

1 month ago

Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering

BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (“Monte Rosa”) (Nasdaq: GLUE), a clinical-stage biotechnology company developing…

1 month ago

AquaFit Weight Loss Supplement Investigation: 2026 Thermogenic Research Examines Green Tea, Berberine, and Metabolic Support Ingredients

AURORA, COLORADO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute…

1 month ago

“Best Peptides for Hair Growth” Search Trends Surge as Telehealth Platforms Expand FDA-Approved Medication Access in 2026

Vero Beach, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not…

1 month ago

Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics

Leuven, Belgium. January 8, 2026. Onco3R Therapeutics, a clinical-stage immunology and oncology biotech company dedicated to transforming patients’ lives with…

1 month ago

Engitix Announces $25 Million Series A Extension Financing by Existing Investor Mike Platt to Advance ECM-Targeted Therapeutics in Solid Tumors and Fibrosis

Company has built one of the largest proprietary extracellular matrix (ECM) datasets spanning fibrosis and solid tumors January 08, 2026…

1 month ago

PathAI and University Hospital Zurich Announce Collaboration to Deploy AISight Dx and AIM-TumorCellularity for Routine Molecular Pathology Workflows

January 08, 2026 03:00 ET  | Source: PathAI BOSTON, Mass. and ZURICH, Switzerland, Jan. 08, 2026 (GLOBE NEWSWIRE) -- PathAI,…

1 month ago